| Advantages | Compared to traditional 2D cell lines, they better mimic the in vivo environment and can be used to predict patient responses to therapeutics. Thoroughly characterized and genetically stable, these organoids represent an ideal platform for studying gastrointestinal diseases, drug discovery, and precision medicine. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Duodenum |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | These highly clinically relevant 3D models retain the physiological and molecular characteristics of native duodenal tissue. |
| Applications | Tissue-derived organoids are extensively applied in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By faithfully recapitulating disease states, they provide an optimal platform for evaluating patient-specific drug responses and supporting personalized treatment strategies. Moreover, these organoids drive the development of novel therapeutic modalities, particularly in oncology and tissue regeneration, offering sophisticated experimental tools that accelerate precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.